| 08-Mar-2006 | S | Jubilant Organosys Limited has informed the Exchange that the BODs at its meeting held on January 14, 2006 approved the following: (1) Sub-division of each equity share of Rs.5 (five), whether issued or not, into five equity shares of Re.1 (one) each, subject to approval of Stock Exchanges and Shareholders; and accordingly, to alter the Capital Clause of the
Memorandum of Association of the Company, and (2) Alteration of Objects Clause of Memorandum of Association of the Company, subject to the approval of members, enabling the Company to set up Special Economic Zone(s).
(As per NSE Bulletin dated on 16/01/2006)
The company has informed that the members of the Company, will consider to approve the following Ordinary /Special resoulution by way of postal ballot:
1. Sub-division of each equity share of Rs 5/- into 5 equity shares of Re 1/- each and consequential amendments in the Memorandum of Association of the Company.
2. Alteration of Clause III i.e., Objects Clause of the Memorandum of Association of the Company by inserting new sub-clause 15 after the existing sub-clause 14 in the Main Objects.
The Company has appointed Mr. Tanuj Vohra, Practising Company Secretary, as Scrutinizer for conducting Postal Ballot process in a fair & transparent manner.
The Postal Ballot form duly completed should reach the Scrutinizer on or before March 06, 2006 and the Scrutinizer will submit his report after completion of the scrutiny.
(As per BSE Bulletin dated on 10/02/2006)
The Company has informed that the members of the Company, by way of Postal ballot, have passed the following Ordinary / Special Resolutions, with majority:
1. Sub-division of each equity share of Rs 5/- into 5 equity shares of Re 1/- each and consequential amendments in the Memorandum of Association of the Company.
(As per BSE Bulletin dated on 07/03/2006)
Trading members of the Exchange are hereby informed that, Jubilant Organosys Limited has fixed the Record Date for the purpose of sub
division.
RECORDDATE 24/03/2006
REDUCED PAID-UP VALUE Re.1/-
SUB-DIVIDED PAID-UP VALUEW.E.F. 17/03/2006
Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each.
The auction in the equity shares of Jubilant Organosys Limited in Dematerialised Securities - Rolling Settlement Segment on 17/03/2006, 20/03/2006 and 21/03/2006 will be conducted as per face value of Rs.5/- each. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be No Delivery from 17/03/2006 (DR-243/2005-2006) to 23/03/2006 (DR-247/2005-2006).
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 21/03/2006.
ii. ISIN No. INE700A01025 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 17/03/2006, except for the auction transactions, which will be conducted on 17/03/2006, 20/03/2006 and 21/03/2006 respectively.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As per BSE Notice dated on 08/03/2006) | 24-Mar-2006 | |
| 17-Oct-2002 | S | Sub-division of existing equity share from every one existing equity share of Rs.10/- each into two equity shares of Rs.5/- each.
Reduced Paid-up Value - Re.5/-
Reduced Paid-up Value w.e.f. 12/11/2002 | 21-Nov-2002 | |
| 29-May-2023 | D | Pursuant to Provisions of Regulation 30 and other applicable provisions of Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. on Monday, May 29, 2023 considered and has, inter alia, recommended a dividend of Rs. 5 (Rupees Five only) per equity share of Re. 1 each for the Financial Year ended March 31, 2023. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company will be paid/dispatched within 30 days from the date of Annual General Meeting (AGM).
Intimation of Record Date for the purpose of Declaration of Dividend for the Financial Year 2022-23
(As Per BSE Announcement dated on 31.07.2023) | 10-Aug-2023 | |
| 27-May-2022 | D | The Board of Directors of the Company has, at its meeting held today i.e. on May 27, 2022, recommended a dividend of Rs. 5 (Rupees Five only) per equity share of Re. 1 each for the year ended March 31, 2022. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid/ despatched on or before September 7, 2022. We request you to take the same on record. | 11-Aug-2022 | |
| 04-Jun-2021 | D | Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. on June 4, 2021, recommended a dividend of Rs. 5 (Rupees five only) per equity share of Re.1 each for the year ended March 31, 2021. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before October 20, 2021.
We request you to take the same on record.
| 05-Aug-2021 | |
| 27-Feb-2020 | D | Board declared interim dividend @ 500% i.e. Rs. 5 per Equity Share of Re. 1 each on the paid-up Equity Share capital of the Company for the Financial Year 2019-20.
| 09-Mar-2020 | |
| 17-May-2019 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 17, 2019, inter alia, has recommended a dividend of Rs. 4.50 (Four Rupees and Fifty Paisa only) per equity share of Re. 1 each for the year ended March 31, 2019. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before October 24, 2019. | 12-Sep-2019 | |
| 09-May-2018 | D | Dear Sirs, Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. on May 9, 2018, recommended a dividend of Rs. 3 (Rupees Three only) per equity share of Re.1 each for the year ended March 31, 2018. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before October 4, 2018.
| 12-Sep-2018 | |
| 23-May-2017 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2017, inter alia, has recommended a dividend of Rs. 3 (Rupees Three only) per equity share of Re.1 each for the year ended March 31, 2017. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / dispatched on or before September 27, 2017.
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. on May 23, 2017, recommended a dividend of Rs. 3 (Rupees Three only) per equity share of Re.1 each for the year ended March 31, 2017. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before September 27, 2017. | 16-Aug-2017 | |
| 24-May-2016 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2016, has recommended a dividend of Rs. 3 (Rupees Three) per equity share of Re. 1 each for the year ended March 31, 2016. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before September 28, 2016. | 18-Aug-2016 | |
| 12-May-2015 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2015, has recommended a dividend of Rs.3/- (Rupees Three) per equity share of Re.1/- each for the year ended March 31, 2015. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before September 30,2015. | 20-Aug-2015 | |
| 26-May-2014 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2014, inter alia, has recommended a dividend of Rs. 3 per equity shares of Rs. 1 fully paid up amounting to Rs. 5590 lacs, subject to approval in the Annual General Meeting. | 21-Aug-2014 | |
| 07-May-2013 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2013, inter alia, has recommended a dividend of Rs. 3 (Rupees Three) per share of Re. 1/- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid / dispatched on or before September 26, 2013. | 14-Aug-2013 | |
| 07-May-2012 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2012, inter alia, has recommended a dividend of Rs. 3 (Rupees Three) per share of Re. 1 /- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid/despatched on or before September 27, 2012. | 14-Aug-2012 | |
| 10-May-2011 | D | Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2011, inter alia, has recommended a dividend of Rs. 2 (Rupees Two) per share of Re. 1/- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid on or before September 22, 2011. | 10-Aug-2011 | |
| 10-May-2010 | D | Jubilant Organosys Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2010, inter alia, has recommended a dividend of Rs. 2.00 per equity share of Re 1 amounting to Rs. 3703 Lacs, subject to approval in the annual General Meeting. | 17-Sep-2010 | |
| 28-Apr-2009 | D | Jubilant Organosys Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2009, inter alia, has recommended the dividend of 1.50 per equity share, subject to approval in Annual General Meeting. | 29-Jun-2009 | |
| 22-Apr-2008 | D | Jubilant Organosys Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 22, 2008, inter alia, has recommended a dividend of Rs 1.50 of per equity shares of Re 1 totaling to Rs 256.55 million, subject to approval in Annual General Meeting. | 17-Sep-2008 | |
| 27-Apr-2007 | D | Jubilant Organosys Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2007, inter alia, has recommended the dividend of 125% on fully paid up equity shares of Re 1 each, for the year ended March 31, 2007.
| 17-Sep-2007 | |
| 18-Apr-2006 | D | 125% Dividend | 08-Sep-2006 | |
| 03-Mar-2004 | B | THREE Bonus shares for every FIVE existing Equity shares held.
| 15-Mar-2004 | 3:5 |
| 02-Feb-2024 | BC | JUBILANT PHARMOVA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.
Details are as under:
Details
Reason Of Change | 01-Apr-2024 | |
| 26-Mar-2024 | BC | Change in Independent Directors of the Company | 31-Mar-2024 | |
| 29-Mar-2024 | BC | Update on acquisition of stake in O2 Renewable Energy XVI Private Limited | 29-Mar-2024 | |
| 26-Mar-2024 | BC | Outcome of the Board Meeting held on March 26, 2024
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that based on the recommendations of the Nomination, Remuneratio | 26-Mar-2024 | |
| 23-Jan-2024 | BC | Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve Board Meeting Intimation for unaudited st | 02-Feb-2024 | |